Cargando…

Intensity-modulated radiotherapy has superior outcomes to three-dimensional conformal radiotherapy in patients with stage IE-IIE extranodal nasal-type natural killer/T-cell lymphoma

We compared the treatment outcomes, toxicities and prognoses of patients with stage IE-IIE extranodal natural killer/T-cell lymphoma (ENKTL) treated with intensity-modulated radiotherapy (IMRT) or three-dimensional conformal radiotherapy (3DCRT). Newly diagnosed early-stage ENKTL patients (N = 173)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yi-Yang, Lin, Hai-Qun, Zhang, Lu-Lu, Feng, Ling-Ling, Niu, Shao-Qing, Wang, Han-Yu, Zhang, Yu-Jing, Wang, Xi-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601157/ https://www.ncbi.nlm.nih.gov/pubmed/28947989 http://dx.doi.org/10.18632/oncotarget.16138

Ejemplares similares

Salvage radiotherapy improves survival in patients with locoregionally relapsed stage IE–IIE extranodal natural killer/T-cell lymphoma, nasal type
por: Tong, Qin, et al.
Publicado: (2018)

Treatment Outcome of Radiotherapy Alone versus Radiochemotherapy in IE/IIE Extranodal Nasal-Type Natural Killer/T Cell Lymphoma: A Meta-Analysis
por: Deng, Tianxia, et al.
Publicado: (2014)

Gemcitabine, dexamethasone, and cisplatin (GDP) chemotherapy with sandwiched radiotherapy in the treatment of newly diagnosed stage IE/IIE extranodal natural killer/T‐cell lymphoma, nasal type
por: Tian, Shu, et al.
Publicado: (2019)

Prognostic nomogram for overall survival in upper aerodigestive tract extranodal natural killer/T-cell lymphoma, nasal type, stages IE and IIE: A SEER-based study
por: Wang, Gangjian, et al.
Publicado: (2019)

Radiotherapy followed by DICEP regimen in treatment of newly diagnosed, stage IE/IIE, extranodal NK/T‐cell lymphoma patients
por: Liu, Yizhen, et al.
Publicado: (2020)

Five‐year analysis from phase 2 trial of “sandwich” chemoradiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T‐cell lymphoma
por: Zhang, Li, et al.
Publicado: (2015)

A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type
por: Xu, Peng-Peng, et al.
Publicado: (2017)

A Multicenter Retrospective Comparison of Sequential versus Sandwich Chemoradiotherapy for Stage IE-IIE Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
por: Li, Jin, et al.
Publicado: (2018)

Short-Course Versus Long-Course Chemoradiotherapy for Stage IE–IIE Extranodal Natural Killer/T cell Lymphoma, Nasal Type: A Multicenter Retrospective Study
por: Li, Jin, et al.
Publicado: (2018)

Concurrent IMRT and weekly cisplatin followed by GDP chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell lymphoma
por: Ke, Q-H, et al.
Publicado: (2014)

Consolidation Radiotherapy in Stage IE- IIE, Non-Bulky Primary Gastric Diffuse Large B-Cell Lymphoma with Post-Chemotherapy Complete Remission
por: Li, Qiwen, et al.
Publicado: (2015)

Radiotherapy improves survival in early stage extranodal natural killer/T cell lymphoma patients receiving asparaginase-based chemotherapy
por: Li, Yi-Yang, et al.
Publicado: (2016)

Chemotherapy combined with high-dose extended-field radiotherapy for stage I extranodal nasal-type natural killer/T-cell lymphoma
por: Luo, Jialin, et al.
Publicado: (2016)

Pegaspargase Combined with Concurrent Radiotherapy for Early‐Stage Extranodal Natural Killer/T‐Cell Lymphoma, Nasal Type: A Two‐Center Phase II Study
por: Wang, Hua, et al.
Publicado: (2020)

The Roles of Radiotherapy and Chemotherapy in the Era of Multimodal Treatment for Early-Stage Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma
por: Kim, Tae Hyung, et al.
Publicado: (2016)

Development of new prognostic model based on pretreatment βLRI and LLRI for stage IE/IIE upper aerodigestive tract ENKTL, nasal type
por: Dai, Wumin, et al.
Publicado: (2017)

Optimal Courses of Chemotherapy Combined with Radiotherapy for Low-Risk Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Propensity Score Matching Analysis
por: Li, Jin, et al.
Publicado: (2020)

Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma
por: Liu, Xin, et al.
Publicado: (2019)

Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type
por: Gill, Harinder, et al.
Publicado: (2010)

Lymphocyte/Monocyte Ratio is a Novel Predictor for Early Stage Extranodal Natural Killer/T-cell Lymphoma, Nasal Type
por: Wang, Qiao-xuan, et al.
Publicado: (2017)

Skin lesion of extranodal natural killer/T‐cell lymphoma nasal type
por: Okumura, Koichiro, et al.
Publicado: (2021)

Clinicopathological characteristics, local treatment, and prognostic factors in IE/IIE primary breast lymphoma: a retrospective study of 67 patients
por: Feng, Ruigang, et al.
Publicado: (2023)

Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma
por: Niu, Shao-Qing, et al.
Publicado: (2016)

PET/CT aids the staging of and radiotherapy planning for early-stage extranodal natural killer/T-cell lymphoma, nasal type: A case series
por: MacDonald, Shannon L, et al.
Publicado: (2011)

Sequential chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal type
por: Lee, Jieun, et al.
Publicado: (2013)

Sequential P‐GEMOX and radiotherapy for early‐stage extranodal natural killer/T‐cell lymphoma: A multicenter study
por: Zhang, Yuchen, et al.
Publicado: (2021)

Primary Orbital Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type, without Nasal Involvement
por: Jing, Dalan, et al.
Publicado: (2022)

Body mass index as a prognostic factor in patients with extranodal natural killer/T-cell lymphoma, nasal type
por: Liu, Jie, et al.
Publicado: (2016)

A Case of Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type with Dermatomyositis
por: Gong, Yu, et al.
Publicado: (2021)

Primary pulmonary extranodal natural killer/T-cell lymphoma (ENKTL), nasal type: Two case reports and literature review
por: Hu, Qun, et al.
Publicado: (2020)

Histological vascular invasion is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type
por: Wang, Hua, et al.
Publicado: (2016)

Combined use of DDGP and IMRT has a good effect on extranodal natural killer/T‐cell lymphoma, nasal type
por: Zheng, Yingjuan, et al.
Publicado: (2019)

Boletín IIE.
Publicado: (1977)

Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database
por: Liu, Xin, et al.
Publicado: (2023)

Extranodal Natural Killer/T-Cell Lymphoma of the Nasal Type with Skin Metastases
por: Akhrass, Fadi Al, et al.
Publicado: (2016)

Neurolymphomatosis Caused by Nasal-type Extranodal Natural Killer/T-cell Lymphoma
por: Yi, Fang-Fang, et al.
Publicado: (2017)

Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: Diagnosis and Treatment
por: van Doesum, Jaap A., et al.
Publicado: (2021)

Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma
por: Yang, Claire Wen-Chi, et al.
Publicado: (2017)

Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for stage I-II natural killer/T-cell lymphoma nasal type: dosimetric and clinical results
por: Shen, Qianwen, et al.
Publicado: (2013)

Extranodal natural killer/T-cell lymphoma (nasal type) presenting as a perianal abscess: A case report
por: Liu, Yan-Ni, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u5o3ei08l6uq4abpij8kcgsjco